Barclays Maintains Overweight on Fabrinet, Lowers Price Target to $496
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Barclays analyst Tim Long maintains Fabrinet (NYSE:FN) with a Overweight and lowers the price target from $739 to $496.
Barclays analyst Tim Long maintains Fabrinet (NYSE:FN) with a Overweight and lowers the price target from $739 to $496.